Studies on the Regulatory Effect of Cytokine Production in Patients with Cerebral Infarction by Yangkyuksanhwatang

양격산화탕(凉膈散火湯)이 소양인(少陽人) 뇌경색증(腦硬塞症) 환자(患者)의 세포활성물질(細胞活性物質) 생성조절(生成調節)에 미치는 영향(影響)

  • Kim, Kyung-Yo (Dept. of Oriental Medicine, Graduate School of Wonkwang University) ;
  • Kweon, Deog-Yun (Dept. of Oriental Medicine, Graduate School of Wonkwang University)
  • 김경요 (원광대학교 한의과대학 사상의학교실) ;
  • 권덕윤 (원광대학교 한의과대학 사상의학교실)
  • Published : 2000.12.31

Abstract

1. Purpose This studies the regulatory effect of cytokine production in Soyangin patients with cerebral infarction by Yangkyuksanhwatang. 2 Method ELISA 3. Result & Conclusion Yangkyuksanhwatang(YST) is a prescription for the cerebral infarction (CI) patients of Soyangin according to Sasang constitution philosophy. Soyangin patients with CI were treated with YST during the acute stage. Clinical signs of CI disappeared markedly in about 2 to 4 weeks after oral administration of YST in all patients. The mean interleukin (IL)-2 plasma levels were slightly lower in the patients with CI than in the normal groups, whereas the mean IL-4, IL-6 and IgE levels were significantly higher in the patients. There were no significant differences in interferon- ${\gamma}$ (IFN- ${\gamma}$ ) levels between the groups. Serum IFN- ${\gamma}$ and IL-2 levels derived from T helper (Th)1 cells were elevated significantly in the patients with CI by YST administration. Significant reduced plasma levels of IL-4 and IL-6 derived from Th2 cells and IgE were observed in the patients treated with YST. During the period of YST administration, there were no other adverse effects. The data indicate that YST has a good CI treatment effect, and that its action may be due to regulation of cytokine production.

Keywords

References

  1. 동의수세보원 이제마
  2. 경희한의대논문집 v.7 양격산화탕의 효능에 관한 실험적 연구 김진성
  3. 양격산화탕이 고혈압 및 고지혈증에 미치즌 영향 남창규
  4. 태평혜민화제국방 v.육 진사문
  5. 사상의학회지 v.10 no.2 양격산화탕 활용에 대한 임상적 연구 박성식
  6. 면역학 김세종
  7. 사상의학회지 v.9 no.1 태음인 갈근해기탕과 원지상의 갈근해기탕이 면역반응에 미치는 영향 박성식
  8. Proceedings of the National Academy Sciences of the United States of America v.84 Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells Gauldie, J.;Richards, C.;Harnish, D.;Lansdorp, P.;Baumann, H.
  9. Proceedings of the National Academy Sciences of the United States of America v.82 Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2) Hirano, T.;Taga, T.;Nakano, N.;Yasukawa, K.;Kashiwamura, S.;Shimizu, K.;Nakajima, K.;Pyun, K.H.;Kishimoto, T.
  10. Nature v.324 Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin Hirano, T.;Yasukawa, K.;Harada, H.;Taga, T.;Watanabe, Y.;Matsuda, T.;Kashiwamura, S.;Nakajima, K.;Koyama, K.;Iwamatsu, A.(et al.)
  11. Journal of Experimental Medicine v.168 Production of B cell stimulatory factor-2 and interferon gamma in the central nervous system during viral meningitis and encephalitis. Evaluation in a murine model infection and in patients. 16 Frei, K;Leist, T.P;Meager, A;Gallo, P;Leppert, D;Zinkernagel, R.M;Fontana, A
  12. Journal of Neuroimmunology v.23 Human immunodeficiency virus type 1 (HIV-1) infection of the central nervous system: an evaluation of cytokines in cerebrospinal fluid Gallo, P.;Frei, K.;Rordorf, C.;Lazdins, J.;Tavolato, B.;Fontana, A.
  13. Journal of Neuroimmunology v.24 Brain tumors: detection of B-cell stimulatory factor-2/interleukin-6 in the absence of oligoclonal bands of immunoglobulins Leppert, D.;Frei, K.;Gallo, P.;Yasargil, M.G.;Hess, K.;Baumgartner, G.;Fontana, A.
  14. Journal of Immunology v.136 Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins Mosmann, T.R.;Cherwinski, H.;Bond, M.W.;Giedlin, M.A.;Coffman, R.L.
  15. Journal of Clinical Investigation v.88 Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production Del Prete, G.F.;De Carli, M.;Mastromauro, C.;Biagiotti, R.;Macchia, D.;Falagiani, P.;Ricci, M.;Romagnani, S.
  16. J Dairy Sci v.82 no.8 Shifts in bovine CL4 subpopulations increase T-helper-2 compared with T-helper-1 effector cells during the postpartum period Shafer Weaver, K.A.;Corl, C.M.;Sordillo, L.M.
  17. Journal of Immunology v.140 Anti-proliferative effect of IFN-gamma in immune regulation. I. INF-gamma inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones Gajewski, T.F.;Fitch, F.W.
  18. Journal of Experimental Medicine v.170 Recombinant interleukin 4 suppresses the production of interferon gamma by human mononuclear cells Peleman, R.;Wu, J.;Fargeas, C.;Delespesse, G.
  19. Journal of Immunology v.144 IL-4 inhibits the synthesis of IFN-gamma and induces the synthesis of IgE in human mixed lymphocyte cultures Vercelli, D.;Jabara, H.H.;Lauener, R.P.;Geha, R.S.
  20. Basic & Clinical Immunology Daniel P. Stites;Abba I. Terr;Tristram G. Parslow
  21. Lancet v.1 no.344 Reduced interferon-gamma secretion in neonates and subsequent atopy Tang, M.L.;Kemp, A.S.;Thorburn, J.;Hill, D.J.
  22. Current Opinion in Immunology v.3 Regulation of IgE synthesis by cytokines De Vries, J.E.;Gauchat, J.F.;Aversa, G.G.;Punnonen, J.;Gascan, H.;Yssel, H.
  23. Proceedings of the National Academy Sciences of the United States of America v.86 IgE secretion by Epstein-Barr virus-infected purified human B lymphocytes is stimulated by interleukin 4 and suppressed by interferon gamma Thyphronitis, G.;Tsokos, G.C.;June, C.H.;Levine, A.D.;Finkelman, F.D.
  24. Proceedings of the National Academy Sciences of the United States of America v.86 Regulation of immunoglobulin production in hyperimmunoglobulin E recurrent-infection syndrome by interferon gamma King, C.L.;Gallin, J.I.;Malech, H.L.;Abramson, S.L.;Nutman, T.B.
  25. European Journal of Immunology v.20 Regulation of human IgE synthesis. I. Human IgE synthesis in vitro is determined by the reciprocal antagonistic effects of interleukin 4 and interferon-gamma Chretien, I.;Pene, J.;Briere, F.;De Waal Malefijt, R.;Rousset, F.;De Vries, J.E.
  26. Clinical and Experimental Immunology v.85 Serum levels of soluble IL-2 receptor, IL-4 and IgE-binding factors in childhood allergic diseases Matsumoto, T.;Miile, T.;Yamaguchi, K.;Murakami, M.;Kawabe, T.;Yodoi, J.
  27. Immunology Letters v.61 IL-6 antisense oligonucleotides ingibit IgE production in IL-4 and anti-CD40-stimulated human B-lymphocytes Bjorck, P.;Larsson, S.;Andang, M.;Ahrlund-Richter, L.;Paulie, S.
  28. Ann Intern Med v.128 The pathophysiologic roles of interleukin-6 in human disease Papanicolaou, D.A.;Wilder, R.L.;Manolagas, S.C.;Chrousos, G.P.
  29. Clinical and Experimental Immunology v.71 Elevated levels of the 26K human hybridoma growth factor (interleukin 6) in cerebrospinal fluid of patients with acute infection of the central nervous system Houssiau, F.A.;Bukasa, K.;Sindic, C.J.;Van Damme, J.;Van Snick, J.
  30. Current Opinion in Immunology v.2 IgE synthesis Delespesse, G.;Sarfati, M.;Heusser, C.
  31. Immunology Today v.11 Regulation and deregulation of human IgE synthesis Romagnani, S.
  32. Clinical and Experimental Allergy v.21 no.Suppl 1 Regulation of human IgE synthesis Gascan, H.;Gauchat, J.F.;de Waal Malefyt, R.;Schneider, P.;Yssel, H.;de Vries, J.E.
  33. Annual Review of Immunology v.8 Lymphokine control of in vivo immunoglobulin isotype selection Finkelman, F.D.;Holmes, J.;Katona, I.M.;Urban, J.F. Jr.;Beckmann, M.P.;Park, L.S.;Schooley, K.A.;Coffman, R.L.;Mosmann, T.R.;Paul, W.E.
  34. Immunology A short course Eli Benjamini;Sidney Leskowitz
  35. Proceedings of the National Academy Sciences of the United States of America v.86 Regulation of immunoglobulin production in hyperimmunoglobulin E recurrent-infection syndrome by interferon gamma King, C.L.;Gallin, J.I.;Malech, H.L.;Abramson, S.L.;Nutman, T.B.
  36. J Clin Immunol v.19 no.4 Intracerebral production of tumor necrosis factor-alpha, a local neuroprotective agent in Alzheimer disease and vascular dementia Tarkowski, E.;Blennow, K.;Tarkowski, A.
  37. Neurol Res v.21 no.3 Time course of IL-6 expression in experimental CNS ischemia Clark, W.M.;Rinker, L.G.;Lessov, N.S.;Eckenstein, F.